Clinical studies recruiting near Los Alamitos

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · Oncology Physicians Network (OPN)- Los Alamitos · Shanghai Henlius Biotech · NCT07160335 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · United Medical Doctors - Los Alamitos · Eli Lilly and Company · NCT06937086 Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder
Phase 2 · Collaborative Neuroscience Research - Los Alamitos · Rapport Therapeutics Inc. · NCT07046494 Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Meta
Phase 1/Phase 2 · Cancer and Blood Speciality Clinic - Los Alamitos · Institut de Recherches Internationales Servier · NCT06501625 A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P
Phase 2 · Collaborative Neuroscience Network - Los Alamitos- CenExel - · Appello Pharmaceuticals, Inc. · NCT07432958 Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Ob
Phase 3 · United Medical Doctors - Los Alamitos · Eli Lilly and Company · NCT06937099 AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Stud
Phase 2 · Artiva Investigational Site Los Alamitos · Artiva Biotherapeutics, Inc. · NCT06991114 Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina
Phase 2/Phase 3 · TRIO - Cancer & Blood Specialty Clinic - Los Alamitos · Mirati Therapeutics Inc. · NCT04613596 A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
Phase 3 · Otsuka Pharmaceutical Development & Commercialization, Inc. · NCT06894212 A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
Phase 2 · Pharmacology Research Institute (PRI) · Ipsen · NCT06625060 VALOR: Vaginal Atrophy & Long-term Observation of Recovery
NA · WR-PRI, LLC (Los Alamitos) · Stratpharma AG · NCT05953090 Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Phase 3 · Los Alamitos Medical Center · Yale University · NCT03907046 A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
Phase 2 · United Medical Doctors - Los Alamitos · Eli Lilly and Company · NCT07545772 A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
Phase 2 · United Medical Doctors - Los Alamitos · Eli Lilly and Company · NCT07545759 Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar
Phase 1 · Shanghai Henlius Biotech · NCT07176650 A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal
Phase 3 · OPN - Oncology Physician Network (Los Alamitos) · Shanghai Henlius Biotech · NCT06532006 Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder
Phase 3 · WR PRI Los Alamitos · Janssen Research & Development, LLC · NCT06559306

Look up another city

Look up another condition